Pulse.

a daily field guide to health research that matters

◆ Console

‹ Fri · 30 Oct 2026
Standard addition

Comparative analysis of ctDNA-MRD and MVI in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort study.

Blood-based minimal residual disease tracking outperformed traditional imaging for predicting which liver cancer patients will relapse.

This prospective multicenter cohort study examined comparative analysis of ctdna-mrd and mvi in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort study. The PubMed abstract reports longitudinal ctdna minimal-residual-disease status outperformed microvascular invasion for predicting recurrence after hepatocellular carcinoma resection, with the combined model reaching auc values of 0853 to 0899.

What the study was

Study design
Prospective multicenter cohort study
Population
Patients undergoing curative resection for hepatocellular carcinoma
Category
Genomics/Precision Medicine
Maturity
Validated
Journal
Hepatology international

Why it surfaced

Score reflects the prospective multicenter cohort study design and relevance to Precision oncology and genomic medicine; classification is limited to PubMed title, metadata, and abstract evidence.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.